Antifibrinolytic therapy in complex spine surgery: A case-control study comparing aprotinin and tranexamic acid

Orthopedics

Volumn 32, Issue 2, 2009, Pages 91-

  Colomina, Maria J ^a   Bagó, Joan ^a   Vidal, Xavi ^a   Mora, Lidia ^a   Pellisé, Ferran ^a  

^a HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

APROTININ; HEMOGLOBIN; TRANEXAMIC ACID; ANTIFIBRINOLYTIC AGENT;

ADOLESCENT; ADULT; AGED; ARTICLE; BLEEDING; BLOOD TRANSFUSION; CHILD; CONTROLLED STUDY; FEMALE; FIBRINOLYTIC THERAPY; HEMATOCRIT; HUMAN; KYPHOSIS; LAMINECTOMY; MAJOR CLINICAL STUDY; MALE; OPERATION DURATION; OSTEOTOMY; SCHOOL CHILD; SCOLIOSIS; SPINE DISEASE; SPINE FUSION; SPINE SURGERY; SURGICAL APPROACH; SURGICAL TECHNIQUE; TREATMENT OUTCOME; COMPARATIVE STUDY; MIDDLE AGED; RETROSPECTIVE STUDY;

ADOLESCENT; ADULT; AGED; ANTIFIBRINOLYTIC AGENTS; APROTININ; BLOOD LOSS, SURGICAL; BLOOD TRANSFUSION; CHILD; FEMALE; HUMANS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; SPINAL FUSION; TRANEXAMIC ACID; YOUNG ADULT;

EID: 68149160343     PISSN: 01477447     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Meert KL, Kannan S, Mooney JF. Predictors of red cell transfusion in children and adolescents undergoing spinal fusion surgery. Spine. 2002; 27:2137-2142.
2. Erstad BL. What is the evidence for using hemostatic agents in surgery? Eur Spine J. 2004; 13:28-33.
3. Kannan S, Meert KL, Mooney JF, Hillman-Wiseman C, Warrier I. Bleeding and coagulation changes during spinal fusion surgery: a comparison of neuromuscular and idiopathic scoliosis patients. Pediatr Crit Care Med. 2002; 3:364-369.
4. Fox HJ, Thomas CH, Thompson AG. Spinal instrumentation for Duchenne's muscular dystrophy: experience of hypotensive anaesthesia to minimise blood loss. J Pediatr Orthop. 1997; 17:750-753.
5. Nuttall GA, Horlocker TT, Santrach PJ, Oliver WC Jr, Dekutoski MB, Bryant S. Predictors of blood transfusions in spinal instrumentation and fusion surgery. Spine. 2000; 25:596-601. (Pubitemid 30158218)
6. Weis JC, Betz RR, Clements DH, Balsara RK. Prevalence of perioperative complications after anterior spinal fusion for patients with idiopathic scoliosis. J Spinal Disord. 1997; 10:371-375. (Pubitemid 27524105)
7. Cole JW, Murray DJ, Snider RJ, Bassett GS, Bridwell KH, Lenke LG. Aprotinin reduces blood loss during spinal surgery in children. Spine. 2003; 28:2482-2485. (Pubitemid 37386229)
8. Neilipovitz DT. Tranexamic acid for major spinal surgery. Eur Spine J. 2004; 13:62-65.
9. Khoshhal K, Mukhtar I, Clark P, Jarvis J, Letts M, Splinter W. Efficacy of aprotinin in reducing blood loss in spinal fusion for idiopathic scoliosis. J Pediatr Orthop. 2003; 23:661-664. (Pubitemid 37040450)
10. Kokoszka A, Kuflik P, Bitan F, Casden A, Neuwirth M. Evidence-based review of the role of aprotinin in blood conservation during orthopaedic surgery. J Bone Joint Surg Am. 2005; 87:1129-1136. (Pubitemid 40617586)
11. Royston D, Bidstrup BP, Taylor KM, Sapsford RN. Effect of aprotinin on need for blood transfusion after repeat open-heart surgery. Lancet. 1987; 2:1289-1291. (Pubitemid 17156632)
12. Shiga T, Wajima Z, Inoue T, Sakamoto A. Aprotinin in major orthopedic surgery: a systematic review of randomized controlled trials. Anesth Analg. 2005;101:1602-1607. (Pubitemid 41720604)
13. Zufferey P, Merquiol F, Laporte S, et al. Do antifibrinolytics reduce allogeneic blood transfusion in orthopedic surgery? Anesthesiology. 2006;105:1034-1046.
14. Henry DA, Moxey AJ, Carless PA, et al. Anti-fibrinolytic use for minimising perioperative allogeneic blood transfusion. Cochrane Database Syst Rev. 2001; CD001886.
15. Nuttall GA, Horlocker TT, Santrach PJ, Oliver WC Jr, Dekutoski MB, Bryant S. Use of the surgical blood order equation in spinal instrumentation and fusion surgery. Spine. 2000; 25:602-605. (Pubitemid 30158219)
16. Urban MK, Beckman J, Gordon M, Urquhart B, Boachie-Adjei O. The efficacy of antifibrinolytics in the reduction of blood loss during complex adult reconstructive spine surgery. Spine. 2001; 26:1152-1156. (Pubitemid 32429317)
17. Rizzi PE, Winter RB, Lonstein JE, Denis F, Perra JH. Adult spinal deformity and respiratory failure. Surgical results in 35 patients. Spine. 1997; 22:2517-2530.
18. Lisander B, Jonsson R, Nordwall A. Combination of blood-saving methods decreases homologous blood requirements in scoliosis surgery. Anaesth Intensive Care. 1996; 24:555-558. (Pubitemid 26377303)
19. Samama CM. A direct antifibrinolytic agent in major orthopedic surgery. Orthopedics. 2004; 27:675-680.
20. Salido JA, Marin LA, Gomez LA, Zorrilla P, Martinez C. Preoperative hemoglobin levels and the need for transfusion after prosthetic hip and knee surgery: analysis of predictive factors. J Bone Joint Surg Am. 2002; 84:216-220. (Pubitemid 37127482)
21. Neilipovitz DT, Murto K, Hall L, Barrowman NJ, Splinter WM. A randomized trial of tranexamic acid to reduce blood transfusion for scoliosis surgery. Anesth Analg. 2001; 93:82-87. (Pubitemid 32601158)
22. Sethna NF, Zurakowski D, Brustowicz RM, Bacsik J, Sullivan LJ, Shapiro F. Tranexamic acid reduces intraoperative blood loss in pediatric patients undergoing scoliosis surgery. Anesthesiology. 2005; 102:727-732. (Pubitemid 40462851)
23. Lentschener C, Cottin P, Bouaziz H, Mercier FJ, Wolf M, Aljabi Y, Boyer-Neumann C, Benhamou D. Reduction of blood loss and transfusion requirement by aprotinin in posterior lumbar spine fusion. Anesth Analg. 1999; 89:590-597. (Pubitemid 29409802)
24. Amar D, Grant FM, Zhang H, Boland PJ, Leung DH, Healey JA. Antifibrinolytic therapy and perioperative blood loss in cancer patients undergoing major orthopedic surgery. Anesthesiology. 2003; 98:337-342. (Pubitemid 36592799)
25. Cid J, Lozano M. Tranexamic acid reduces allogeneic red cell transfusions in patients undergoing total knee arthroplasty: results of a meta-analysis of randomized controlled trials. Transfusion. 2005; 45:1302-1307. (Pubitemid 41647794)
26. Ho KM, Ismail H. Use of intravenous tranexamic acid to reduce allogeneic blood transfusion in total hip and knee arthroplasty: a meta-analysis. Anaesth Intensive Care. 2003; 31:529-537. (Pubitemid 37265248)
27. Weiskopf RB. If you prick us, do we not bleed? Anesthesiology. 2006; 105:873-876.
28. Mangano DT, Tudor IC, Dietzel C. The risk associated with aprotinin in cardiac surgery. N Engl J Med. 2006; 354:353-365. (Pubitemid 43145060)
29. Mangano DT, Miao Y, Vuylsteke A, et al. Mortality associated with aprotinin during 5 years following coronary artery bypass graft surgery. JAMA. 2007; 297:471-479. (Pubitemid 46220802)
30. Llau JV, Garcia-Perez ML. Increased safety in the administration of aprotinin: need for a test-dose. Anesth Analg. 2000; 90:770-771.
31. Kovesi T, Royston D. Pharmacological approaches to reducing allogeneic blood exposure. Vox Sang. 2003; 84:2-10. (Pubitemid 36564980)